Importance of Evaluating D-Dimer, CRP, LDH, and RBS as Predictors in the Severity of COVID-19 Disease: Omicron Variant
Medical Science Journal for Advance Research · 22.04.2026 · 7 (1)
DOI: 10.46966/msjar.v7i1.383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Journal for Advance Research, online erschienen am 22.04.2026. Verfasst von Zainab Mohsin Ali Alrubayei und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
COVID-19 is associated with systemic inflammation, coagulation abnormalities, and metabolic disturbances that contribute to disease severity. Biomarkers such as D-dimer, C-reactive protein (CRP), and lactate dehydrogenase (LDH) have been identified as potential severity predictors, yet their combined diagnostic value and the influence of demographic factors remain incompletely characterized.
Objective
To evaluate inflammatory, coagulation, and metabolic biomarkers in patients with moderate-to-severe COVID-19 and assess the influence of age and gender on these parameters.
Methods
This cross-sectional study enrolled 260 hospitalized COVID-19 patients confirmed by quantitative reverse transcription polymerase chain reaction (RT-qPCR) and 50 healthy controls. Serum and plasma levels of D-dimer, CRP, LDH, and random blood sugar (RBS) were measured using fully automated apparatus methods. Statistical analysis included t-tests and analysis of variance to compare parameters across groups and demographic strata.
Results
COVID-19 patients demonstrated significantly elevated D-dimer (863.17 ± 39.06 ng/ml, p < 0.0001), CRP (24.31 ± 2.08 mg/L, p = 0.0055), and LDH (443.09 ± 43.88 U/L, p < 0.00001) levels compared to controls. RBS levels were also significantly elevated (p < 0.05). Gender had no strong independent effect on these biomarkers; however, CRP showed significant age-related differences in males (p < 0.05), while LDH demonstrated significant age-related elevation in both sexes (p < 0.001). Diabetic COVID-19 patients exhibited substantially higher glucose levels independent of gender.
Conclusion
D-dimer, CRP, and LDH are valuable biomarkers for assessing disease severity in moderate-to-severe COVID-19, with LDH showing pronounced age-dependent elevation. These markers may serve as useful indicators for monitoring clinical progression and identifying high-risk patients, particularly among diabetic populations.
Zitieren
APA
Alrubayei, Z. M. A., Naser, I. H., Jawad, N. M., & Jameel, Z. I. (2026). Importance of Evaluating D-Dimer, CRP, LDH, and RBS as Predictors in the Severity of COVID-19 Disease: Omicron Variant. Medical Science Journal for Advance Research, 7(1). https://doi.org/10.46966/msjar.v7i1.383
Vancouver
Alrubayei ZMA, Naser IH, Jawad NM, Jameel ZI. Importance of Evaluating D-Dimer, CRP, LDH, and RBS as Predictors in the Severity of COVID-19 Disease: Omicron Variant. Medical Science Journal for Advance Research. 2026;7(1). doi:10.46966/msjar.v7i1.383
BibTeX
@article{Alrubayei2026,
author = {Alrubayei, Zainab Mohsin Ali and Naser, Israa Habeeb and Jawad, Noor Muhsin and Jameel, Zahraa Isam},
title = {Importance of Evaluating D-Dimer, CRP, LDH, and RBS as Predictors in the Severity of COVID-19 Disease: Omicron Variant},
journal = {Medical Science Journal for Advance Research},
year = {2026},
volume = {7},
number = {1},
doi = {10.46966/msjar.v7i1.383}
}
EUVIMED